Di-(2-ethylhexyl)-phthalate (DEHP), an ubiquitous environmental contaminant, has been shown to cause adverse effects on glucose homeostasis and insulin sensitivity in epidemiological studies, but the underlying mechanisms are still unknown. We therefore tested the hypothesis that chronic DEHP exposure causes impaired insulin sensitivity, affects body weight, adipose tissue (AT) function and circulating metabolic parameters of obesity resistant 129S6 mice in vivo. An obesity-resistant mouse model was chosen to reduce a potential obesity bias of DEHP effects on metabolic parameters and AT function. The metabolic effects of 10-weeks exposure to DEHP were tested by insulin tolerance tests and quantitative assessment of 183 metabolites in mice. Furthermore, 3T3-L1 cells were cultured with DEHP for two days, differentiated into mature adipocytes in which the effects on insulin stimulated glucose and palmitate uptake, lipid content as well as on mRNA/protein expression of key adipocyte genes were investigated.We observed in female mice that DEHP treatment causes enhanced weight gain, fat mass, impaired insulin tolerance, changes in circulating adiponectin and adipose tissue Pparg, adiponectin and estrogen expression. Serum metabolomics indicated a general increase in phospholipid and carnitine concentrations. In vitro, DEHP treatment increases the proliferation rate and alters glucose uptake in adipocytes. Taken together, DEHP has significant effects on adipose tissue (AT) function and alters specific serum metabolites. Although, DEHP treatment led to significantly impaired insulin tolerance, it did not affect glucose tolerance, HOMA-IR, fasting glucose, insulin or triglyceride serum concentrations. This may suggest that DEHP treatment does not cause impaired glucose metabolism at the whole body level.

Modern indoor environments contain a vast array of contaminating sources. Emissions from these sources produce contaminant concentrations that are substantially higher indoors than outside. Because we spend most of our time indoors, exposure to indoor pollutants may be orders-of-magnitude greater than that experienced outdoors. Phthalate esters have been recognized as major indoor pollutants. They are mainly used as plasticizers to enhance the flexibility of polyvinylchloride (PVC) products, as well as in humectants, emollients, and antifoaming agents. Phthalates are found in a wide range of consumer products including floor and wall coverings, car interior trim, floor tiles, gloves, footwear, insulation on wiring, and artificial leather. Because these phthalate additives are not chemically bound to the polymer matrix, slow emission from the products to the surrounding air or other media usually occurs. Biomonitoring data suggest that over 75% of the U.S. population is exposed to phthalates. The ubiquitous exposure to phthalates is of concern because toxicological investigations have demonstrated considerable adverse health effects of phthalates and their metabolites. Studies have shown that exposure to phthalates results in profound and irreversible changes in the development of the reproductive tract, especially in males, raising the possibility that phthalate exposures could be the leading cause of reproductive disorders in humans. In addition, effects such as increases in prenatal mortality, reduced growth and birth weight, skeletal, visceral, and external malformations are possibly associated with phthalate exposure. Epidemiologic studies in children also show associations between phthalate exposure in the home and the risk of asthma and allergies. Given the ubiquitous nature of phthalates in the environment and the potential for adverse human health impacts, there is a critical need to understand indoor emissions of phthalates and to identify the most important sources and pathways of exposure. In this study, a model that integrates the fundamental mechanisms governing emissions of semi-volatile organic compounds (SVOCs) from polymeric materials and their subsequent interaction with indoor surfaces and airborne particles was developed. The emissions model is consistent with analogous mechanistic models that predict emission of volatile organic compounds (VOCs) from building materials. Reasonable agreement between model predictions and gas-phase di-2-ethylhexyl phthalate (DEHP) concentrations was achieved for data collected in a previously published experimental study that measured emissions of DEHP from vinyl flooring in two very different chambers. The analysis showed that while emissions of highly volatile VOCs are subject to “internal“ control (through the material-phase diffusion coefficient), emissions of the very low volatility SVOCs are subject to “external“– control (through partitioning into the gas phase, the convective mass transfer coefficient, and adsorption onto interior surfaces). Because of the difficulties associated with sampling and analysis of SVOCs, only a few chamber studies quantifying their emissions from building materials and consumer products are available. To more rigorously validate the SVOCs emission model and more completely understand the mechanisms governing the release of phthalate from polymeric building materials, the emission of DEHP from vinyl flooring was studied for up to 140 days in a specially-designed stainless steel chamber. In the duplicate chamber study, the gas-phase concentration in the chamber increased slowly and reached a steady state level of 0.9 µg/m3 after 30 days. By increasing the area of vinyl flooring and decreasing that of the stainless steel surface in the chamber, the time to reach steady state was significantly reduced, compared to the previous study (1 month vs. 5 months). The adsorption isotherm of DEHP on the interior stainless steel chamber surface was explicitly measured using two different methods (solvent extraction and thermal desorption). Strong adsorption of DEHP onto the stainless steel surface was observed and found to follow a simple linear relationship. In addition, parameters measured in the experiments were then applied in the fundamental SVOCs emission model. Good agreement was obtained between the predictions of the model and the gas-phase DEHP chamber concentrations, without resorting to fitting of model parameters. These chamber studies have shown that the tendency of SVOCs to adsorb strongly to interior surfaces has a very strong influence on the emission rate. Compared to the experimental chamber systems, however, the real indoor environment has many other types of surface that will adsorb phthalates to different extents. The emission rate measured in a test chamber may therefore be quite different to the emission rate from the same material in the indoor environment. For this reason, both a two-room model and a more representative three-compartment model were developed successively to estimate the emission rate of DEHP from vinyl flooring, the evolving gas-phase and adsorbed surface concentrations, and human exposures (via inhalation, dermal absorption and oral ingestion of dust) in a realistic indoor environment. Adsorption isotherms for phthalates and plasticizers on interior surfaces, such as carpet, wood, dust and human skin, were derived from previous field and laboratory studies. A subsequent sensitivity analysis revealed that the vinyl flooring source characteristics, as well as mass-transfer coefficients and ventilation rates, are important variables influencing the steady-state DEHP concentration and resulting exposures. A simple uncertainty analysis suggested that residential exposure to DEHP originating from vinyl flooring may fall somewhere between about 5 µg/kg/d and 180 µg/kg/d. The roughly 40-fold range in exposure reveals the inherent difficulty in using biomonitoring results to identify specific sources of exposure in the general population. This research represents the first attempt to explicitly elucidate the fundamental mechanisms governing the release of phthalates from polymeric building materials as well as their subsequent interaction with interior surfaces. The mechanistic models developed can most likely be extended to predict concentration and exposure arising from other sources of phthalates, other sources of other semi-volatile organic compounds (such as biocides and flame retardants), as well as emissions into other environmental media (food, water, saliva, and even blood). The results will be of value to architects, governments, manufacturers, and engineers who wish to specify low-emitting green materials for healthy buildings. It will permit health professionals to identify and control health risks associated with many of the SVOCs used in indoor materials and consumer products in a relatively inexpensive way. / Ph. D.

2011年5月臺灣爆發不肖業者將具有毒性之塑化劑添加入合法食品添加物─起雲劑當中，販賣給多家食品業者，用以生產各種食品及飲料，戕害國民健康。惟案件中消費者僅獲賠求償額的兩千分之一，差距甚大，明顯不如預期，更是引發社會諸多撻伐。本論文藉由上述塑化劑案件，探討食品安全消費訴訟消費者求償困境並檢討現行法的缺失與不足，以符合消費者權益保障之宗旨。 文章中首先針對食品安全消費訴訟特性以及我國食品管制上主管機關的權責劃分進行概念性介紹，並就訴訟中消費者可主張的民法、消費者保護法、食品安全衛生管理法上請求權基礎進行要件及爭點說明。其次，就損害賠償之概念及損害進行界定與討論。另由於此類型訴訟，消費者食用問題產品後，多半不會產生立即性身體傷害或臨床病徵，導致訴訟上消費者就其所受之損害難以舉證而敗訴，故本文藉由參酌美國毒物侵權行為訴訟上之損害認定，將損害概念擴張至損害或「損害之虞」，以解決訴訟上消費者損害認定不易的難題。 此外，於因果關係舉證方面，則藉由德國環境責任法、德國基因科技法上之原因推定理論、美國法上市場佔有率責任之因果關係以及日本法上疫學因果關係理論，作為此類型訴訟我國因果關係認定之參考，並就損害賠償範圍、我國懲罰性賠償金制度的引進、目的、重要爭點等析述討論之。最後，本論文藉由實務上判決，觀察現行食品安全衛生管理法第56條法院適用情形，從中檢討現行條文不盡完備之處，並嘗試提出相關修法建議，希冀可作為將來立法者修法之參考。 / In May, 2011 the Taiwan Food and Drug Administration reported that plasticizers, such as: di(2-ethylhexyl)phthalate (DEHP) and di(iso-nonyl)phthalate (DINP), were illegally added to clouding agents used in foods and several beverages.The endocrine disruptors have been linked to developmental problems with children and pregnant women, etc.This paper would mainly discuss the issues of the reflection of civil liabilities arising from food scandals, particularly focus on the plasticizer food scandal in Taiwan. First, the author gives an overview of consumer litigation of food safety, food administration in Taiwan, and the basic of claim such as the Civil law, the Act Governing Food Safety and Sanitation as well as the Consumer Protection Law.Secondly, interprets the concept of civil compensationand expand the traditional concept of personal injury to risk of injury (the plaintiff has not manifested any symptoms of disease but may suffer from illness in the future) by referring to toxic tort.Thirdly, illustrates the special rules on causation in the aspect of the environmental liability law, the biotech law and the market share liability to solve the problems of the causation.Fourthly,probes the compensation scope and punitive damages. Finally,by observing court decisions on article 56 of the Act Governing Food Safety and Sanitation, the author analyzes the deletion of existing legal norms and suggests a proposal for law amendments.

El di(2-etilhexil) ftalat (DEHP) és un plastificant que s’afegeix als productes de clorur de polivinil (PVC) per a dotar-los de més flexibilitat. El material mèdic fet de PVC, i en particular els dispositius i bosses que s’utilitzen en les transfusions de sang, conté el DEHP com additiu. Així, el receptor d’una transfusió està altament exposat a aquest compost. L’objectiu de la tesi va ser estudiar els metabòlits del DEHP en orina com a possibles marcadors de la pràctica d’una transfusió de sang en l’esport. Es va desenvolupar i validar un mètode d’anàlisi per cromatografia líquida acoblada a espectrometria de masses en tàndem per a la quantificació dels principals metabòlits del DEHP en orina humana: mono-(2-etilhexil) ftalat (MEHP), mono-(2-etil-5-hidroxihexil) ftalat (MEHHP), mono-(2-etil-5-oxohexil) ftalat (MEOHP), mono-(2-carboximetilhexil) ftalat (2cx-MMHP) i mono-(2-etil-5-carboxipentil) ftalat (5cx-MEPP). El mètode es va aplicar a mostres procedents de voluntaris sans (grup control), de pacients hospitalitzats que havien rebut una transfusió de sang i de pacients hospitalitzats sotmesos a tractaments mèdics amb materials de PVC i no a transfusions. Es van obtenir diferències significatives en les concentracions dels tres metabòlits estudiats (MEHP, MEHHP, MEOHP) entre les mostres dels pacients transfosos respecte els altres dos grups de població. El mètode també es va aplicar a mostres d’orina de vint-i-cinc voluntaris sans que s’havien sotmès a un procediment d’autotransfusió. Els resultats van indicar concentracions elevades dels cinc metabòlits del DEHP en orina fins a les 48 hores després d’haver rebut la sang. Finalment, es van determinar les concentracions dels cinc metabòlits de DEHP en una població d’esportistes i es van calcular límits de referència que permetessin sospitar d’una transfusió. Així doncs, els resultats indiquen que la mesura dels metabòlits de DEHP en orina pot ser usada com una eina pel cribatge de l’ús de transfusions en l’esport. / The plasticizer di(2-ethylhexyl)phthalate (DEHP) is used in polyvinyl chloride products (PVC) to increase its flexibility. Medical devices made of PVC, especially blood bags used in blood transfusions, contain DEHP as additive. Therefore, subjects submitted to blood transfusion are widely exposed to this compound. The aim of the project was to evaluate DEHP metabolites in urine as possible markers of the use of a blood transfusion in sports. An analytical method was developed and validated to quantify the main DEHP metabolites mono-(2-ethylhexyl)phthalate (MEHP), mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP), mono-(2-ethyl-5-oxohexyl)phthalate (MEOHP), mono-(2-carboxymethylhexyl)phthalate (2cx-MMHP) and mono-(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP), in human urine by liquid chromatography tandem mass spectrometry. The methodology was applied to samples belonging to healthy volunteers (control group), hospitalized patients subjected to blood transfusions and hospitalized patients subjected to medical treatments involving plastic material different to blood transfusions. Significant differences were obtained in the concentrations of the three metabolites studied (MEHP, MEHHP, MEOHP) between transfused patients samples’ and the other two population groups. The method was also applied to urine samples from twenty-five healthy volunteers who were subjected to an autologous blood transfusion. The results indicated high concentrations of the five DEHP metabolites in urine up to 48 hours after the blood transfusion. Finally, the concentration of the five DEHP metabolites were evaluated in a sportsmen population and reference limits to allow suspicion of blood transfusion were calculated. Thus, the results indicate that the DEHP metabolites could be used as markers of blood transfusions in sports.